Vaccine and treatment evaluation
Ended Awarded Last action
- Contract number
- HHSN27200015
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,051,802
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (vteu) Award Notice · Posted Mar 29, 2012
- Contract value 34% obligated
-
- $1,051,801.78 Current, with exercised options
- $3,128,475.78 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Atlanta, GA 30322, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,573,961 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,343,689 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,282,074 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports the evaluation of vaccines and treatments for infectious diseases. The contract has a ceiling value of $3,128,475.78 and a period of performance through December 31, 2020. The University of Rochester is a key subcontractor, providing services related to the evaluation of treatments for complicated urinary tract infections (cUTI) under the VTEU program. This contract award does not have a set-aside designation. Emory University is a major recipient of federal research funding and has an extensive track record of conducting clinical trials and biomedical research for government agencies.
Quick answers
Who was awarded contract HHSN27200015?
HHSN27200015 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 14, 2016.
How much is contract HHSN27200015 worth?
The government has obligated $1,051,802 on HHSN27200015. Its potential value, with all options, is $3,128,476.
Is contract HHSN27200015 an order under another contract?
Yes. HHSN27200015 is a delivery order under HHSN272201300018I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200015 competed?
The extent of competition for HHSN27200015 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award